1,271 results on '"Singh, Nina"'
Search Results
152. Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts
153. Hemolytic uremic syndrome in solid-organ transplant recipients
154. Invasive aspergillosis in the recipients of liver retransplantation
155. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality
156. Strategies To Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients
157. Preemptive therapy for cytomegalovirus
158. Decreased incidence of viral infections in liver transplant recipients: Possible effects of FK506?
159. Posttransplant Fever in Critically Ill Organ Transplant Recipients
160. Severing the Gordian knot of prevention of cytomegalovirus in liver transplant recipients: The principle is the sword
161. Who Among Cytomegalovirus-Seropositive Liver Transplant Recipients Is at Risk for Cytomegalovirus Infection?
162. Bleeding complications precipitated by unrecognized Gingko biloba use after liver transplantation
163. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
164. Prospective Assessment of Platelia™ Aspergillus Galactomannan Antigen for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients
165. Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates
166. Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy
167. STAPHYLOCOCCUS AUREUS RECTAL CARRIAGE AND ITS ASSOCIATION WITH INFECTIONS IN PATIENTS IN A SURGICAL INTENSIVE CARE UNIT AND A LIVER TRANSPLANT UNIT
168. Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients
169. Prevention of Antibiotic Resistance in Hospitals
170. SHORT-COURSE EMPIRIC ANTIBIOTIC THERAPY FOR PATIENTS WITH PULMONARY INFILTRATES IN THE INTENSIVE CARE UNIT
171. Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy
172. Adherence to Protease Inhibitors
173. Fungal infections in the recipients of solid organ transplantation
174. Short-course Empiric Antibiotic Therapy for Patients with Pulmonary Infiltrates in the Intensive Care Unit: A Proposed Solution for Indiscriminate Antibiotic Prescription
175. Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
176. Prophylactic Fluconazole in Liver Transplant Recipients
177. Rational Empiric Antibiotic Prescription in the ICU*: Clinical Research Is Mandatory
178. Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis1
179. Editorial: Oral Ganciclovir Usage for Cytomegalovirus Prophylaxis in Organ Transplant Recipients: Is Emergence of Resistance Imminent?
180. Fever in liver transplant recipients in the intensive care unit1
181. Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness
182. Nasal Carriage of and Infection with Staphylococcus aureus in HIV-Infected Patients
183. MRI Reveals Human Brown Adipose Tissue Is Rapidly Activated in Response to Cold
184. Unique Rarity of Tuberculosis and Granulomatous Opportunistic Infections in Hematopoietic Cell Transplant Recipients
185. Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis
186. LB21. Preemptive Therapy (PET) vs. Prophylaxis for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Donor Seropositive/Recipient Seronegative (D+R−) Liver Transplant Recipients (LTR): A NIH-Sponsored, Randomized, Controlled, Multicenter Trial
187. Herpes zoster-associated idiopathic thrombocytopenic purpura in a liver transplant recipient: a case report and overview
188. Pulmonary Infiltrates in the Surgical ICU*: Prospective Assessment of Predictors of Etiology and Mortality
189. Oral Ganciclovir Usage for Cytomegalovirus Prophylaxis in Organ Transplant Recipients: Is Emergence of Resistance Imminent?
190. Indinavir-associated hepatitis in patients with advanced HIV infection
191. Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus
192. Infections in solid-organ transplant recipients
193. Cytomegalovirus and Death in Liver Transplantation
194. Bloodstream infections in liver transplant recipients receiving tacrolimus
195. Intensive care unit management in liver transplant recipients: beneficial effect on survival and preservation of quality of life*
196. Psychological stress and depression in older patients with intravenous drug use and human immunodeficiency virus infection: implications for intervention
197. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus
198. Cholecystoduodenal Fistula
199. Pulmonary nodules in liver transplant recipients
200. Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.